Tuberculosis

Active Projects: 1

Project
 		Investigator All Topics Start date End date
Targeted HIV/TB Strategic Information Technical Assistance for President's Emergency Plan for AIDS Relief (PEPFAR) and Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) Countries George Rutherford, MD HIV/AIDS, Tuberculosis, Policy and Standards of Care, Epidemiology and Surveillance, Training and Capacity Building, Training International Scholars and Clinicians

Active Projects: 235

Project
 		Investigator All Topics Start date End date
1180: From DOT to DAT: An evaluation of 99DOTS to improve tuberculosis treatment adherence in Uganda Adithya Cattamanchi, MD Tuberculosis, Treatment Adherence
2.1 Project Title ACTG: AIDS Clinical Trials Group Francesca Aweeka, PharmD Infectious Disease, HIV/AIDS, Tuberculosis
3HP for LTBI in Immigrants Pilot Study Payam Nahid, MD, MPH Tuberculosis
A Novel Proteomic Approach to Tuberculosis Biomarker Discovery using Human Exosomes Tuberculosis
A User-Friendly Epidemic-Economic Model of Diagnostic Tests for Tuberculosis Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development, Epidemiology and Surveillance
Accelerating and Intensifying Tuberculosis Case Finding in Uganda Tuberculosis, Residencies, Fellowships, and Postdoctoral Training
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Anne Luetkemeyer, MD HIV/AIDS, Tuberculosis
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Diane Havlir, MD HIV/AIDS, Tuberculosis
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and Uninfected Pulmonary Tuberculosis Suspects Diane Havlir, MD HIV/AIDS, Tuberculosis
Adherence Monitoring impact in Global Health - Planning Grant Rada Savic, PhD Tuberculosis, Treatment Adherence
AIDS Clinical Trial Group (ACTG) Tuberculosis TSG Services Diane Havlir, MD HIV/AIDS, Tuberculosis
AIDS Clinical Trial Research Group (ACTG), Studies: A5306, A5254, A5298 Diane Havlir, MD HIV/AIDS, Opportunistic Infection, Tuberculosis, Oral Health
AIDS Clinical Trials Network (ACTG) - Transformative Science Group Vice Chair) Peter Hunt, MD Infectious Disease, HIV/AIDS, Tuberculosis
Antigen export in M. tuberculosis evasion of CD4 T cells Joel D. Ernst, MD Tuberculosis, Immunology
Assessing the Acceptability and Feasibility of Using a Video-Based Education Curriculum for Tuberculosis Prevention and Control in Pyuthan District, Nepal Shrishti Bhattarai, MS Tuberculosis, Patient and Peer Education
ATS Implementation Guide and Training Modules Philip Hopewell, MD Tuberculosis, Training and Capacity Building
Automated smear-positive tuberculosis diagnosis Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development
BCP and HBAC Cost-Effectiveness Analysis George Rutherford, MD HIV/AIDS, Tuberculosis, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence, Health Systems Strengthening, Training and Capacity Building, Patient and Peer Education
Biostatistical analysis of Mycobacterium Tuberculosis Biomarkers for Diagnosis and Cure Rada Savic, PhD Tuberculosis, Drug and Diagnostics Development
Building Evidence for Advancing New Treatment For XDR/XDR-TB (BEAT TUBERCULOSIS) Study Patrick Phillips, PhD, MS, MA Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Pharmacology and Drug Treatment
Capacity Building for Management of First Line Drug Resistant TB in Tanzania Elizabeth Fair, PhD, MPH Tuberculosis, Training and Capacity Building
Cellular and Bacterial Dynamics in Tuberculosis Joel D. Ernst, MD Tuberculosis, Immunology
Cepheid 077B-C: Evaluation of the Xpert® MTB/RIF Assay Anne Luetkemeyer, MD Tuberculosis
Childhood Tuberculosis Infection Among School-Age Children in Rural Uganda Carina Marquez, MD HIV/AIDS, Tuberculosis, Pediatrics, Epidemiology and Surveillance
Childhood Tuberculosis Infection Among School-Age Children in Rural Uganda Carina Marquez, MD Tuberculosis, Pediatrics
Clinical and Public Health Impact of Automated Nucleic Acid Testing (Cepheid GeneXpert) to Rule-out Tuberculosis in San Francisco Tuberculosis
Clinical trials to improve the treatment of drug-sensitive and MDR-TB Patrick Phillips, PhD, MS, MA Tuberculosis, Immunology, Pharmacology and Drug Treatment
Combining 3HP with active case finding to maximize the impact of mass TB screening campaign in the Marshall Islands Christina Yoon, MD, MPH Tuberculosis, Diabetes, Epidemiology and Surveillance, Engagement in Care
Commission on Investing in Health (CIH) Phase 3: Leveraging Global Health 2035 to Shape the SDGs and the Health Investments of Donor, Low-Income and Middle-Income Countries Tuberculosis, Malaria, Women's Health, Policy and Standards of Care, Systematic Reviews and Guideline Development
Comparative Effectiveness of Rapid Diagnostics for Tuberculosis in Uganda Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development, Epidemiology and Surveillance
Compilation, Synthesis and Grading of Evidence for Questions 5 and 6 Elizabeth Fair, PhD, MPH Tuberculosis, Systematic Reviews and Guideline Development
Conduct a systematic review of interventions to improve adherence and retention during TB and HIV co-treatment among people living with HIV Payam Nahid, MD, MPH HIV/AIDS, Tuberculosis, Systematic Reviews and Guideline Development, Treatment Adherence
Conducting Infection Control Assessment and Developing Educational Materials for Mexico Philip Hopewell, MD Tuberculosis
Continuing Education for Health Professionals for tuberculosis patient care Lisa Chen, MD Tuberculosis, Residencies, Fellowships, and Postdoctoral Training
Continuing Education for the Curry Center Lisa Chen, MD Tuberculosis
Controlling Tuberculosis: A Cost-Effectiveness Analysis of the Drone Observed Therapy System as an Alternative Diagnostic and Treatment Method in Nepal Brittney Butler, MS Tuberculosis, Health Economics and Effectiveness
Coordination of the Development of Tuberculosis Contact Investigation Policy Philip Hopewell, MD Tuberculosis, Policy and Standards of Care
CORE B: Intracellular Pathogens and Innate Immunity Joseph Derisi, PhD Tuberculosis, Immunology
Core Prevention and Control Project Philip Hopewell, MD Tuberculosis
Core Requirements: Tuberculosis Epidemiologic Studies Consortium Elizabeth Fair, PhD, MPH Tuberculosis
De Facto Monotherapy during Multidrug Tuberculosis Treatment and Emergence of Resistance Rada Savic, PhD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
Determination of the M. tuberculosis proteome interaction map (iMAP) during persistence Tuberculosis
Development of an Integrated Social Franchising/ Health Co-op Model to Address TB and HIV among Poor in Sub-Saharan Africa Dominic Montagu, DrPH HIV/AIDS, Tuberculosis, Health Economics and Effectiveness
Diabetes and Tuberculosis in Brazilian slum settings Jayant Rajan, MD Tuberculosis, Noncommunicable and/or Chronic Disease, Diabetes, Occupational and Environmental Disease, Access or Barriers to Care, Stigma and Discrimination
Diagnostics, management, & transmission of MDR TB John Metcalfe, MD Tuberculosis
Discovery of novel, ubiquitin-regulated mechanisms of TB control by macrophages Tuberculosis, Immunology
Doris Duke Charitable Foundation International Clinical Research Fellowship Program Joel Palefsky, MD HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Oral Health, Neurology and Mental Health, Women's Health, Pediatrics, Newborn and Infant Health, Immigration and Migration, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
DOT (Directly observed therapy) Diary Eric Vittinghoff, PhD HIV/AIDS, Tuberculosis
Drug-Resistant Tuberculosis on the Texas-Mexico Border: Improving the Quality of bi-national TB Projects Camila Hurtado, MS Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
East Africa IEDEA Regional Consortium Craig Cohen, MD, MPH HIV/AIDS, Tuberculosis, Cancer/Oncology, Epidemiology and Surveillance
Effect of Drug Resistance on Transmissibility and Pathogenicity of M. Tuberculosis Philip Hopewell, MD Tuberculosis
Effectiveness of QuantiFERON-TB Gold (QFT-G) in Contact Tracing Elizabeth Fair, PhD, MPH Tuberculosis, Drug and Diagnostics Development
Effects of Air Pollution on Childhood Tuberculosis in Viet Nam Tuberculosis, Pediatrics
Engagement and retention in tuberculosis care services among people living with HIV in Lusaka, Zambia: does gender matter?​ Andrew Kerkhoff, MD, PhD HIV/AIDS, Tuberculosis, Stigma and Discrimination, Engagement in Care, Treatment Adherence
Evaluating the Impact of Cash Transfers on Tuberculosis (TB) Care: ExaCT TB Study Priya Shete, MD Tuberculosis, Health Economics and Effectiveness, Implementation and Behavioral Science
Evaluation of interferon Gamma Release Assays in Overseas Immigration Examination of Children in Moderate and high Burden Countries Elizabeth Fair, PhD, MPH Tuberculosis, Pediatrics
Evaluation of Novel Tuberculosis Screening Strategies for People living with HIV Christina Yoon, MD, MPH HIV/AIDS, Tuberculosis
Evaluation of Point-of-Care C-reactive Protein Assay as a Serial Screening Tool for Active Tuberculosis among People Living with HIV in Uganda Paul Park, MS Tuberculosis
Evaluation of Smear Microscopy Methods Philip Hopewell, MD Tuberculosis, Policy and Standards of Care, Systematic Reviews and Guideline Development
Evaluation of the performance of rapid, non-sputum based, biomarker-based test for tuberculosis (TB) diagnosis Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development
Evidence Reviews required for the revision of the WHO guidance on the treatment of TB. Payam Nahid, MD, MPH Tuberculosis, Policy and Standards of Care, Systematic Reviews and Guideline Development
Exhaled Breath Biomarkers for the Diagnosis of TB in Children Devan Jaganath, MD Tuberculosis, Drug and Diagnostics Development, Pediatrics
Exhaled Breath Biomarkers for the Diagnosis of TB in Children Devan Jaganath, MD Tuberculosis, Drug and Diagnostics Development
Exosomes as Biomarkers for Tuberculosis Tuberculosis
Expand New Drug Markets for TB (endTB) Patrick Phillips, PhD, MS, MA Tuberculosis, Epidemiology and Surveillance
Exploring the role of a novel, polymorphic protein family in M. tuberculosis pathogenesis Tuberculosis, Immunology
Family-Based HIV Voluntary Testing and Counseling in Patients at Risk for Tuberculosis Edwin Charlebois, PhD HIV/AIDS, Tuberculosis, Implementation and Behavioral Science
FIND Xpert MTB assay collaboration at Mulago Hospital Laurence Huang, MD Tuberculosis
First Lancet Commission Meeting 11-13 July 2017, San Francisco, California Eric Goosby, MD Tuberculosis, Policy and Standards of Care
Fitness Cost and Compensation in Quinolone-Resistant Mycobacterium tuberculosis Midori Kato-Maeda, MD Tuberculosis
From Poverty to Cure: Overcoming Socioeconomic Barriers to Tuberculosis Care Priya Shete, MD Tuberculosis, Implementation and Behavioral Science
Frontloaded Sputum Microscopy Tuberculosis
Global Fund Prospective Country Evaluations George Rutherford, MD Infectious Disease, Tuberculosis, Malaria, Women's Health, Pediatrics
Global Fund SR2020 Starley Shade, PhD, MPH Infectious Disease, Tuberculosis, Malaria
Health Education Videos for Tuberculosis Management in Remote Madagascar Hailey Reeves, MS Tuberculosis, Patient and Peer Education
HIV/TB in Uganda: Punctuated Antiretroviral Therapy Diane Havlir, MD HIV/AIDS, Tuberculosis
HIV/TB in Uganda: Punctuated Antiretroviral Therapy Diane Havlir, MD HIV/AIDS, Tuberculosis
Host-Directed Strategies to Create Synergistic Antibacterial Therapies Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development, Immunology
HQHIV1003203 Philip Hopewell, MD HIV/AIDS, Tuberculosis
Human-centered Design and Communities of Practice to Improve Delivery of Home-based Tuberculosis Contact Investigation in Uganda Adithya Cattamanchi, MD HIV/AIDS, Tuberculosis, Engagement in Care
Identifying Optimal Treatment Strategies for Tuberculosis Treatment Rada Savic, PhD Tuberculosis, Pharmacology and Drug Treatment
Immunodiagnosis of Active Tuberculosis in HIV-Infected Patients Adithya Cattamanchi, MD HIV/AIDS, Tuberculosis, Drug and Diagnostics Development
Impact of Pregnancy on Tuberculosis Rada Savic, PhD Tuberculosis, Women's Health, Labor and Delivery, Newborn and Infant Health
Impact of Pregnancy on Tuberculosis Rada Savic, PhD Tuberculosis, Pharmacology and Drug Treatment, Women's Health, Labor and Delivery, Newborn and Infant Health
Impact of the Number of Contacts on the Transmission of Tuberculosis - a Molecular Epidemiologic Study Payam Nahid, MD, MPH Tuberculosis, Epidemiology and Surveillance
Implementation of The Global Fund's Programmatic Quality Assurance and Improvement Approach George Rutherford, MD HIV/AIDS, Tuberculosis, Malaria
Improving care delivery for people living with HIV, TB and other chronic diseases through diplomacy Michael J. Reid, MD Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening
Improving Early Identification of Drug Resistant Tuberculosis in HIV Prevalent Settings John Metcalfe, MD HIV/AIDS, Tuberculosis
Improving the efficiency of clinic-based active tuberculosis case finding: point-of-care C-reactive protein-based TB triage testing in Vietnam​ Christina Yoon, MD, MPH Tuberculosis, Drug and Diagnostics Development
Improving the molecular diagnosis of drug resistant tuberculosis Midori Kato-Maeda, MD Tuberculosis, Drug and Diagnostics Development
Improving urine-based tuberculosis diagnosis in people living with HIV​ Devan Jaganath, MD Tuberculosis, Drug and Diagnostics Development
Infectious disease laboratories George Rutherford, MD Infectious Disease, Tuberculosis
Integrative Pharmacology Approach to Understand Mechanisms of Tuberculosis Drug Resistance Rada Savic, PhD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development
Interferon-Gamma Release Assays for the Diagnosis of Tuberculosis in Adults Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development
Intergovernmental Personnel Agreement (IPA) Eric Goosby, MD HIV/AIDS, Tuberculosis
International Clinical Research Fellowship Christopher Stewart, MD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Francesca Aweeka, PharmD HIV/AIDS, Tuberculosis, Malaria, Women's Health, Pediatrics, Adolescent Health
Interplay of Strain and Ethnicity in the Immune Response to M. tuberculosis Payam Nahid, MD, MPH Tuberculosis
Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers (DIPT 1/2) Judith Hahn, PhD, MD HIV/AIDS, Tuberculosis, Substance Abuse, Treatment Adherence
Investigation of Indoor Solid Fuel and Kerosene Use as Tuberculosis Risk Factors Philip Hopewell, MD Tuberculosis
Investigation of M. tuberculosis Cytochrome P450 Involvement in Cholesterol Utilization Tuberculosis
Lesion Drug Penetration and Translational Modeling Rada Savic, PhD Tuberculosis, Drug and Diagnostics Development
Lesion-centric imaging and PK-PD of pyrazinamide for TB/HIV co-infection Rada Savic, PhD Tuberculosis
Leukopheresis Testing Payam Nahid, MD, MPH Tuberculosis
LOC-IMPAACT Leadership Group Francesca Aweeka, PharmD HIV/AIDS, Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment, Women's Health, Pediatrics, Newborn and Infant Health, Systematic Reviews and Guideline Development
M tuberculosis Cells from Patients with Tuberculosis Midori Kato-Maeda, MD Tuberculosis
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse James Kahn, MD, MPH HIV/AIDS, Tuberculosis, Health Economics and Effectiveness
Manipulation of Macrophage Responses by M. Tuberculosis Tuberculosis
Manipulation of Macrophage Responses by M. tuberculosis Tuberculosis
Manipulation of Macrophage Responses by M. tuberculosis Tuberculosis
Master Agreement: Tuberculosis Epidemiologic Studies Consortium Philip Hopewell, MD Tuberculosis
Master Agreement: Tuberculosis Indefinite Quantity Contract (TB IQC) Philip Hopewell, MD Tuberculosis
Mechanism-Based Integrative Pharmacology Model for Tuberculosis Rada Savic, PhD Tuberculosis, Pharmacology and Drug Treatment
Mobile Health for Implementation of Home-based TB Contact Investigation in Uganda Tuberculosis, Implementation and Behavioral Science
Mobile Health for Implementation of Home-based TB Contact Investigation in Uganda Adithya Cattamanchi, MD Tuberculosis, Epidemiology and Surveillance
Mobile Phone Platform for Genomic Disease Detection Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development, Genetics
Model Tuberculosis Education and Training Center Philip Hopewell, MD Tuberculosis, Training and Capacity Building
Modeling the Reproducibility of Blood Assays for TB Infection Adithya Cattamanchi, MD Tuberculosis
Modernization of Phase 3 TB Clinical Trial Endpoints Patrick Phillips, PhD, MS, MA Tuberculosis, Pharmacology and Drug Treatment, Systematic Reviews and Guideline Development
Molecular Epidemiology and Geospatial Analysis of Tuberculosis Transmission in Uganda Gabriel Chamie, MD HIV/AIDS, Tuberculosis, Epidemiology and Surveillance
Mozambique Tuberculosis Prevalence Survey (TGF 016-104) George Rutherford, MD Tuberculosis, Epidemiology and Surveillance
Mozambique Tuberculosis Prevalence Survey (TGF 016-104) George Rutherford, MD HIV/AIDS, Tuberculosis
Multiscale System Pharmacology Disease Platform for Tuberculosis Rada Savic, PhD Tuberculosis
Nonlinear Mixed Effects Modeling of Rifapentine in Children Rada Savic, PhD Tuberculosis, Pediatrics
Nonlinear Mixed Effects Modeling of Rifapentine Pharmacokinetics Rada Savic, PhD Tuberculosis, Pharmacology and Drug Treatment
Novel Biomarkers to Shorten TB Treatment Rada Savic, PhD Tuberculosis
Novel Maltodextrin-Based, Bacterial Targeting Probes for Bioimaging of Viable MTB in Vivo Payam Nahid, MD, MPH Tuberculosis, Drug and Diagnostics Development
Novel Maltodextrin-Based, Bacterial Targeting Probes for Bioimaging of Viable MTB In Vivo Payam Nahid, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development
Novel methods for monitoring long-term drug exposure and resistance amplification during treatment of multidrug resistant tuberculosis John Metcalfe, MD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development
Novel methods of pharmacologic monitoring for multidrug resistant tuberculosis treatment in the setting of HIV infection John Metcalfe, MD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
Novel Techniques for the Detections of Pediatric Tuberculosis in Ethiopia Caryn Bern, MD, MPH Tuberculosis, Pediatrics
Novel Technologies to Increase the Accessibility and Accuracy of Tuberculosis Diagnostic Services in Hanoi Province, Vietnam Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development
Office of the UN Special Envoy for Tuberculosis Eric Goosby, MD Tuberculosis, Policy and Standards of Care
Operations Research Training Curriculum for Tuberculosis Control Lisa Chen, MD Tuberculosis
Optimal MDR treatment in children Rada Savic, PhD Tuberculosis, Pediatrics
Optimal MDR treatment in children Rada Savic, PhD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development, Health Economics and Effectiveness
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-infected Ugandans HIV/AIDS, Tuberculosis, Drug and Diagnostics Development
Overcoming socioeconomic barriers to TB care: the case for social protection Priya Shete, MD Tuberculosis, Engagement in Care, Treatment Adherence
Oxygen Sensors and P450 Monooxgenases in Mycobacterium tuberculosis Tuberculosis
Oxygen Sensors and P450 Monooxygenases in Mycobacertium tuberculosis Tuberculosis, Immunology
PanACEA Patrick Phillips, PhD, MS, MA Tuberculosis, Epidemiology and Surveillance
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases Laurence Huang, MD HIV/AIDS, Tuberculosis, Noncommunicable and/or Chronic Disease
Pharmacokinetics and tolerability of adjunctive linezolid for the treatment of tuberculous meningitis Felicia Chow, MD HIV/AIDS, Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment
Point-of-care C-reactive protein-based tuberculosis screening among people living with HIV: planning a comparative effectiveness trial Christina Yoon, MD, MPH HIV/AIDS, Tuberculosis
Point-of-care C-reactive protein-based tuberculosis screening in people living with HIV: a randomized trial Christina Yoon, MD, MPH Tuberculosis
Population-Based Molecular Epidemiology of Tuberculosis Philip Hopewell, MD Tuberculosis
Population-Based Molecular Epidemiology of Tuberculosis in San Francisco Philip Hopewell, MD Tuberculosis, Epidemiology and Surveillance
Prevalence of baseline and longitudinal heteroresistant M. tuberculosis and association with patient-important outcomes John Metcalfe, MD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
Programmatic Implementation and Technical Assistance (TA) for HIV/AIDS and Tuberculosis (TB) Prevention, Care and Treatment Services throughout the Health System in South Africa George Rutherford, MD HIV/AIDS, Tuberculosis, Engagement in Care, Treatment Adherence
Programmatic Implementation and Technical Assistance (TA) for HIV/AIDS and Tuberculosis (TB) Prevention, Care, and Treatment Services throughout the Health System in South Africa under the President's Emergency Plan Timothy Lane, PhD, MPH HIV/AIDS, Tuberculosis, Access or Barriers to Care, Stigma and Discrimination
Protein secretion in bacterial pathogens Oren Rosenberg, MD, PhD Tuberculosis
Quantiferon+Pamp Payam Nahid, MD, MPH Tuberculosis
REAC AWARD-Using mobile technologies and community health workers to find and support TB contacts in Beira, Mozambique Elizabeth Fair, PhD, MPH Tuberculosis, Epidemiology and Surveillance
Real-Time Reagent-Free Noninvasive Diagnosis of Tuberculosis Payam Nahid, MD, MPH Tuberculosis
Recent Infection Surveillance Consortium George Rutherford, MD HIV/AIDS, Tuberculosis
Redefining Tuberculosis Meningitis with Metagenomics and Host Transciptomics Michael Wilson, MD Tuberculosis, Drug and Diagnostics Development
Redefining Tuberculous Meningitis Diagnostics with Metagenomic Next Generation Sequencing Prashanth Ramachandran, MBBS Tuberculosis, Drug and Diagnostics Development
Regional Capacity Building in Low Incidence Areas Philip Hopewell, MD Tuberculosis, Epidemiology and Surveillance, Engagement in Care
Regional TB Training and Medical Consultation Center (RTMCC) Philip Hopewell, MD Tuberculosis, Training and Capacity Building
Regional TB Training and Medical Consultation Center (RTMCC) Philip Hopewell, MD Tuberculosis, Training and Capacity Building
Regional TB Training and Medical Consultation Center (RTMCC) Philip Hopewell, MD Tuberculosis, Training and Capacity Building
Regional Training and Medical Consultation Center Lisa Chen, MD Tuberculosis
Regional Training and Medical Consultation Center Lisa Chen, MD Tuberculosis
Regulation of ESX-1 secretion and its role in M. tuberculosis virulence Tuberculosis
Regulation of ESX-1 Secretion and Its Role in Mycobacterium tuberculosis Virulence Tuberculosis
Role of Antigen-Specific T Cell Responses in the Control of TB Joel D. Ernst, MD Tuberculosis, Immunology
Role of MmpL Transporters in M. Tuberculosis Virulence Tuberculosis
SEARCH (Sustained East Africa Research in Community Health) Study in Kenya and Uganda/ Gates Diane Havlir, MD HIV/AIDS, Tuberculosis, Malaria, Cardiovascular Disease, Diabetes
Secretion of Virulence Factors by Mycobacterium tuberculosis Infectious Disease, HIV/AIDS, Tuberculosis, Genetics
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden Diane Havlir, MD HIV/AIDS, Tuberculosis
SIngle-saMPLE tuberculosis evaluation to facilitate linkage to care: The SIMPLE TB trial Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development
Sputum M. tuberculosis DNA Kinetics during TB Treatment in Patients with HIV HIV/AIDS, Tuberculosis
Sputum Processing Methods Tuberculosis, Drug and Diagnostics Development
Sputum Transcriptomic Expression Profiling in Study 31 (STEPS 31) Payam Nahid, MD, MPH Tuberculosis, Drug and Diagnostics Development
Sputum Transcriptomic Expression Profiling in Study 31: Express 31 Payam Nahid, MD, MPH HIV/AIDS, Tuberculosis
Streamlined TB Diagnosis Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development
Structural and functional studies of M. tuberculosis type VII secretion Oren Rosenberg, MD, PhD Tuberculosis
Structural Genomics of Persistence Targets from M. Tuberculosis Tuberculosis
Surveilling the syndemic: Assessment of an integrated tuberculosis and HIV pilot surveillance system in Haiti Kristiana Dhillon, MS HIV/AIDS, Tuberculosis
Systematic Review Series on "Antibody and Antigen Detection for the Immunodiagnosis of Tuberculosis" Philip Hopewell, MD Tuberculosis, Immunology, Systematic Reviews and Guideline Development
Systematic Review Series: Non-commercial antibody detection for the dx of pulmonary TB Payam Nahid, MD, MPH Tuberculosis, Systematic Reviews and Guideline Development
Systematic Reviews of the Scientific Bases of Antituberculosis Chemotherapy ("Dogma" Review) Philip Hopewell, MD Tuberculosis, Systematic Reviews and Guideline Development
Tackling Tuberculous Meningitis on the Ground: Bringing Advanced Diagnostics to Uganda Prashanth Ramachandrani, MBBS Tuberculosis, Drug and Diagnostics Development, Neurology and Mental Health, Training International Scholars and Clinicians
Targeted Behavioral Incentives for Improving Tuberculosis (TB) Diagnostic Evaluation Outcomes Priya Shete, MD HIV/AIDS, Tuberculosis
Targeted Testing and Treatment of Latent TB Infection Philip Hopewell, MD Tuberculosis
Targeting host autophagy for treating Mtb infections and synergizing with antibiotics in vivo Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Pharmacology and Drug Treatment
Task Order #22 Assessing the Integration of Social Network Analysis into Tuberculosis Contact Investigation Practice Philip Hopewell, MD Tuberculosis, Epidemiology and Surveillance
Task Order Supplement to A5267 Diane Havlir, MD HIV/AIDS, Tuberculosis, Pharmacology and Drug Treatment
TB Diagnosis Technology Adithya Cattamanchi, MD Tuberculosis
TB Free California Shereen Katrak, MD MPH Tuberculosis, Stigma and Discrimination, Epidemiology and Surveillance
TB Guideline Observation and Adherence in Low Income Countries (TB GOAL) Adithya Cattamanchi, MD Tuberculosis, Systematic Reviews and Guideline Development
TB Physician Services Payam Nahid, MD, MPH Tuberculosis, Epidemiology and Surveillance, Implementation and Behavioral Science
TB Physician Services Payam Nahid, MD, MPH Tuberculosis
TB Physician Services Contract Payam Nahid, MD, MPH Tuberculosis, Epidemiology and Surveillance, Implementation and Behavioral Science
TB Physician Services Contract Payam Nahid, MD, MPH Tuberculosis
TB Physician Services Contract Payam Nahid, MD, MPH Tuberculosis
TB Physician Services Contract Payam Nahid, MD, MPH Tuberculosis
TB Surrogate Markers for Assessing Response to Treatment (TB SMART Study) Payam Nahid, MD, MPH Tuberculosis
TB Surrogate Markers for Assessing Response to Treatment (TB SMART Study) Payam Nahid, MD, MPH Tuberculosis, Drug and Diagnostics Development
TB TO 2015 Philip Hopewell, MD Tuberculosis
TBRU: Tuberculosis Research Unit, Case Western Reserve University Philip Hopewell, MD Tuberculosis, Training and Capacity Building
Technical Assistance to CDC-Ukraine, Network ACCESS-Pro and the Ukrainian Public Health Center George Rutherford, MD HIV/AIDS, Infectious Disease, Transfusion Medicine, Tuberculosis, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians
Technical Assistance: The National Tuberculosis and Leprosy Control Program: MDR/XDR TB Curry International Tuberculosis Center University of California, San Francisco Philip Hopewell, MD Tuberculosis
The impact of TB co-infection on the reservoir of persistent HIV in vivo Mike McCune, MD, PhD HIV/AIDS, Tuberculosis, Immunology
The Yield of Tuberculosis Contact Investigation in Low-Resource, High-Burden Settings: A Systematic Review and Meta-Analysis Mariana Velleca, MS Tuberculosis, Systematic Reviews and Guideline Development, Epidemiology and Surveillance
To carry out re-analysis of data from 5 studies on use Loop-mediated Isothermal Amplication (TB-Lamp) technology for rapid TB diagnostics, stratification of results and reporting Adithya Cattamanchi, MD Tuberculosis, Systematic Reviews and Guideline Development
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV Judith Hahn, PhD, MD HIV/AIDS, Tuberculosis, Substance Abuse, Residencies, Fellowships, and Postdoctoral Training
Transcriptional alterations in bronchoalveolar lavage fluid during treatment of human tuberculosis. Laurence Huang, MD Tuberculosis
Transcriptional alternations in bronchoalveolar lavage fluid during treatment of human tuberculosis Laurence Huang, MD HIV/AIDS, Tuberculosis
Tuberculosis contact tracing in resource poor settings Elizabeth Fair, PhD, MPH Tuberculosis, Epidemiology and Surveillance
Tuberculosis Epidemiologic Studies George Rutherford, MD Tuberculosis, Epidemiology and Surveillance
Tuberculosis Epidemiologic Studies Consortium George Rutherford, MD Tuberculosis
Tuberculosis Epidemiologic Studies Consortium George Rutherford, MD Tuberculosis
Tuberculosis Epidemiologic Studies Consortium George Rutherford, MD Tuberculosis, Epidemiology and Surveillance
Tuberculosis Epidemiologic Studies Consortium Project George Rutherford, MD Tuberculosis
Tuberculosis Epidemiology and Novel Transmission Routes in Rural Tanzania Philip Hopewell, MD Tuberculosis, Epidemiology and Surveillance
Tuberculosis Free California George Rutherford, MD Tuberculosis
Tuberculosis guidelines and best practices internationally Sarah Royce, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis
Tuberculosis Risk Reduction Project George Rutherford, MD Tuberculosis, Systematic Reviews and Guideline Development, Epidemiology and Surveillance
Tuberculosis Risk Reduction Project George Rutherford, MD Tuberculosis, Implementation and Behavioral Science, Risk Reduction and Prevention
Tuberculosis Training Scholarships (TBTS) Philip Hopewell, MD Tuberculosis, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
Tuberculosis Trial Consortium Payam Nahid, MD, MPH Tuberculosis
Tuberculosis Trials Consortium (TBTC) Payam Nahid, MD, MPH Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment
UCB-UCSF-MU Research Training on Tuberculosis (TB) and Other Pulmonary Complications of HIV HIV/AIDS, Opportunistic Infection, Tuberculosis, Chronic Respiratory Disease, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians
UCSF-FIND Uganda Project Laurence Huang, MD Tuberculosis, Drug and Diagnostics Development
UCSF-GIVI Center for AIDS Research (CFAR) Paul Volberding, MD HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Drug and Diagnostics Development, Immunology, Pharmacology and Drug Treatment, Neurology and Mental Health, Trauma and PTSD, Women's Health, Pediatrics, Implementation and Behavioral Science, Training and Capacity Building, Training International Scholars and Clinicians
UCSF-GIVI CFAR East Africa Regional Director HIV/AIDS, Tuberculosis, Malaria, Training and Capacity Building, Training International Scholars and Clinicians
UN Special Envoy for Tuberculosis: Strategic Priorities Eric Goosby, MD Tuberculosis, Health Economics and Effectiveness, Policy and Standards of Care
Uncovering How Mycobacterium Tuberculosis Utilizes a Novel Protein Secretion System to Manipulate Host Response During Infection Tuberculosis
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Infectious Disease, HIV/AIDS, Tuberculosis, Malaria, Surgery and Anesthesia, Cancer/Oncology, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Pediatrics, Policy and Standards of Care, Epidemiology and Surveillance
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training
URBAN ARCH (3/5) Uganda Cohort - TB preventive therapy for HIV-infected alcohol users in Uganda: an evaluation of safety, tolerability, and adherence, Hahn U01 Renewal Judith Hahn, PhD, MD HIV/AIDS, Tuberculosis, Substance Abuse
Utility of Contact Investigation of Drug Susceptible and Resistant Tuberculosis in Tanzania Elizabeth Fair, PhD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Epidemiology and Surveillance
WHO Cochrane: Programmatic Management of Drug Resistant Tuberculosis (PMDT) Tuberculosis

Active Investigators: 1